J Korean Ophthalmol Soc.  2008 Jun;49(6):886-890. 10.3341/jkos.2008.49.6.886.

Corneal Endothelial Change After Intravitreal Triamcinolone Injection

• Ryu EH
• Lee JH
• Lee SY
• Jun RM

• KMID: 2110867
• DOI: http://doi.org/10.3341/jkos.2008.49.6.886

Abstract

PURPOSE: To evaluate the corneal endothelial cell changes after intravitreal triamcinolone (4 mg/0.1 ml, Acedolone(R), Kuhnil) injection.
METHODS
From October 2006 to January 2007, 20 eyes of 19 patients who received intravitreal triamcinolone injection were enrolled. We analyzed the changes of the corneal endothelial cells prospectively and compared them with 11 phakic eyes (group 1) and 9 pseudophakic eyes (group 2) using specular microscopy.
RESULTS
The mean age of the patients was 65.9+/-8.5 years. The preoperative cell densities were 2534.1+/-303.6 in group 1 and 2105.9+/-328.0 in group 2 (p=0.01, Mann Whitney U test). The preoperative coefficients of variation of cell area were 34.6+/-9.7 in group 1 and 31.6+/-7.5 in group 2 (p>0.05), and the preoperative hexagonalities were 56.4+/-13.8 in group 1 and 66.4+/-20.4 in group 2 (p>0.05). The differences between preoperative and postoperative cell densities, coefficients of the variation of cell area, and hexagonalities were not statistically significant in either group (p>0.05).
CONCLUSIONS
There was no clinically significant change in corneal endothelial cells after intravitreal triamcinolone injection.

Keyword

Corneal endothelial cell; Triamcinolone

MeSH Terms

Cell Count
Endothelial Cells
Eye
Humans
Prospective Studies
Triamcinolone
Triamcinolone

Reference

References

1. Danis RP, Ciulla TA, Pratt LM, Ankliker W. Intravitreal triamcinolone actinide in exudative age‐ related macular degeneration. Retina. 2000; 20:244–50.

2. Martidis A, Duker JS, Greenberg PB. . Intravitreal triamninolone for refractory diabetic macular oedema. Ophthalmology. 2002; 109:920–7.

3. Cekic O, Chang S, Tseng JJ. . Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2005; 25:851–5.

4. Sakamoto T, Miyazaki M, Hisatomi T. . Triamcinolone- assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood‐ ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol. 2002; 240:423–9.

5. Yamakiri K, Uchino E, Kimura K, Azad RV. Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery. Am J Ophthalmol. 2004; 138:650–2.

6. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003; 87:24–7.

7. Gillies MC, Simpson JM, Billson FA. . Safety of an intravitreal injection of triamcinolone. Arch Ophthalmol. 2004; 122:336–40.

8. Moshfeghi DM, Kaiser PK, Scott IU. . Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2004; 137:1158–9.

9. Chang YS, Tseng SY, Tseng SH. . Triamcinolone acetonide suspension toxicity to corneal endothelial cells. J Cataract Refract Surg. 2006; 32:1549–55.

10. Oh JY, Wee WR, Lee JH, Kim MK. Short-term effect of intracameral triamcinolone acetonide on corneal endothelium using the rabbit model. Eye. 2006; 10:1038–44.

11. Chan CK, Fan DS, Chan WM. . Ocular‐ hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6‐ month follow‐ up study. Eye. 2005; 19:625–30.

12. Nelson ML, Tennant MT, Sivalingam A. . Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003; 23:686–91.

13. Sharma MC, Lai WW, Shapiro MJ. Pseudohypopyon following intravitreal triamcinolone acetonide injection. Cornea. 2004; 23:398–9.

14. Chen SD, Lochhead J, McDonald B, Patel CK. Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema. Br J Ophthalmol. 2004; 88:843–4.

15. Beer PM, Bakri SJ, Singh RJ. . Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003; 110:681–6.

16. Yee RW, Matsuda M, Schultz RO, Edelhauser HF. Changes in the normal corneal endothelial cellular pattern as a function of age. Curr Eye Res. 1985; 4:671–8.

17. Bourne WM, Kaufman HE. Cataract extraction and the corneal endothelium. Am J Ophthalmol. 1976; 82:44–7.

18. Bourne WM, Kaufman HE. Specular microscopy of human corneal endothelium in vivo. Am J Ophthalmol. 1976; 81:319–23.

19. Bandi N, Kompella UB. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol. 2001; 425:109–16.